Role of Ubiquitination in IGF-1 Receptor Signaling and Degradation
Open Access
- 4 April 2007
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 2 (4) , e340
- https://doi.org/10.1371/journal.pone.0000340
Abstract
The insulin-like growth factor 1 receptor (IGF-1R) plays numerous crucial roles in cancer biology. The majority of knowledge on IGF-1R signaling is concerned with its role in the activation of the canonical phosphatidyl inositol-3 kinase (PI3K)/Akt and MAPK/ERK pathways. However, the role of IGF-1R ubiquitination in modulating IGF-1R function is an area of current research. In light of this we sought to determine the relationship between IGF-1R phosphorylation, ubiquitination, and modulation of growth signals. Wild type and mutant constructs of IGF-1R were transfected into IGF-1R null fibroblasts. IGF-1R autophosphorylation and ubiquitination were determined by immunoprecipitation and western blotting. IGF-1R degradation and stability was determined by cyclohexamide-chase assay in combination with lysosome and proteasome inhibitors. IGF-1R autophosphorylation was found to be an absolute requirement for receptor ubiquitination. Deletion of C-terminal domain had minimal effect on IGF-1 induced receptor autophosphorylation, however, ubiquitination and ERK activation were completely abolished. Cells expressing kinase impaired IGF-1R, exhibited both receptor ubiquitination and ERK phosphorylation, however failed to activate Akt. While IGF-1R mutants with impaired PI3K/Akt signaling were degraded mainly by the proteasomes, the C-terminal truncated one was exclusively degraded through the lysosomal pathway. Our data suggest important roles of ubiquitination in mediating IGF-1R signaling and degradation. Ubiquitination of IGF-1R requires receptor tyrosine kinase activity, but is not involved in Akt activation. In addition we show that the C-terminal domain of IGF-1R is a necessary requisite for ubiquitination and ERK phosphorylation as well as for proteasomal degradation of the receptor.Keywords
This publication has 50 references indexed in Scilit:
- β-Arrestin and Mdm2 Mediate IGF-1 Receptor-stimulated ERK Activation and Cell Cycle ProgressionJournal of Biological Chemistry, 2007
- Paraptosis: mediation by MAP kinases and inhibition by AIP-1/AlixCell Death & Differentiation, 2004
- Cyclolignans as Inhibitors of the Insulin-Like Growth Factor-1 Receptor and Malignant Cell GrowthCancer Research, 2004
- Caveolin-1 Null (−/−) Mice Show Dramatic Reductions in Life SpanBiochemistry, 2003
- Akt Activation Promotes Degradation of Tuberin and FOXO3a via the ProteasomeJournal of Biological Chemistry, 2003
- Phosphorylation of HDM2 by AktOncogene, 2002
- Role of the Insulin-Like Growth Factor Family in Cancer Development and ProgressionJNCI Journal of the National Cancer Institute, 2000
- Insulin-like Growth Factor-I Receptor Internalization Regulates Signaling via the Shc/Mitogen-activated Protein Kinase Pathway, but Not the Insulin Receptor Substrate-1 PathwayJournal of Biological Chemistry, 1998
- Evidence for a Differential Interaction of SHC and the Insulin Receptor Substrate-1 (IRS-1) with the Insulin-like Growth Factor-I (IGF-I) Receptor in the Yeast Two-hybrid SystemPublished by Elsevier ,1995
- Ligand-Induced Transformation by a Noninternalizing Epidermal Growth Factor ReceptorScience, 1990